Dennis Cho - 23 Feb 2026 Form 4 Insider Report for Twist Bioscience Corp (TWST)

Role: Senior Vice President, Chief Legal Officer & Corporate Secretary
Signature: /s/ Kendra Fox, as Attorney-in-Fact for Dennis Cho
Issuer symbol: TWST
Transactions as of: 23 Feb 2026
Net transactions value: -$39,423
Form type: 4
Filing time: 25 Feb 2026, 16:05:11 UTC
Previous filing: 13 Feb 2026
Next filing: 10 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Cho Dennis	Senior Vice President, Chief Legal Officer & Corporate Secretary	C/O TWIST BIOSCIENCE CORPORATION, 681 GATEWAY BLVD, SOUTH SAN FRANCISCO	/s/ Kendra Fox, as Attorney-in-Fact for Dennis Cho	25 Feb 2026	0001883451

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TWST	Common Stock	Sale	$39,423	-844	-0.6%	$46.71	138,682	23 Feb 2026	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
F2	Includes shares that were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Content

Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

Includes shares that were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Remarks:

Senior Vice President, Chief Legal Officer & Corporate Secretary